144
Views
26
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C

, &
Pages 577-585 | Received 04 Apr 2005, Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xin Gao, Jennifer M Stephens, John A Carter, Seema Haider & Vinod K Rustgi. (2012) Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C. Expert Review of Pharmacoeconomics & Outcomes Research 12:3, pages 335-343.
Read now
Mathias Lidgren, Anna Hollander, Ola Weiland & Bengt Jönsson. (2007) Productivity improvements in hepatitis C treatment: Impact on efficacy, cost, cost-effectiveness and quality of life. Scandinavian Journal of Gastroenterology 42:7, pages 867-877.
Read now

Articles from other publishers (24)

Ahreum Seo & Angela Y. Chang. (2024) A systematic review of the social impact of diseases in Nordic countries. Scandinavian Journal of Public Health.
Crossref
Gergely Horváth, Teodóra Keleti, Mihály Makara, Gabor S. Ungvari & Gábor Gazdag. (2018) Effect of hepatitis C infection on the quality of life. Perspectives in Psychiatric Care 54:3, pages 386-390.
Crossref
D. Salmon, M. U. Mondelli, M. Maticic & J. E. Arends. (2018) The benefits of hepatitis C virus cure: Every rose has thorns. Journal of Viral Hepatitis 25:4, pages 320-328.
Crossref
Luigi Elio Adinolfi, Riccardo Nevola, Luca Rinaldi, Ciro Romano & Mauro Giordano. (2017) Chronic Hepatitis C Virus Infection and Depression. Clinics in Liver Disease 21:3, pages 517-534.
Crossref
Hiroto TANAKA & Hideyuki SASAKI. (2017) <b>Cognitive impairment with interferon treatment in patients with chronic hepatitis</b><b> C </b>. Biomedical Research 38:6, pages 371-374.
Crossref
Mitsuyuki Suzuki, Toru Ishikawa, Ai Sakuma, Satoshi Abe, Hiroko Abe, Fujiko Koyama, Tomomi Nakano, Aya Ueki, Hirohito Noguchi, Erina Hasegawa, Shiori Yamagata, Miki Kobayashi, Kazutaka Ohashi, Hiroshi Hirosawa, Takako Fukazawa, Yuka Maruyama & Toshiaki Yoshida. (2016) Evaluation of the health-related quality of life using the 36-item short form health survey in patients with chronic hepatitis C receiving pegylated interferon/ribavirin/telaprevir triple treatment. Experimental and Therapeutic Medicine 12:5, pages 3353-3358.
Crossref
Zobair M. Younossi, Maria Stepanova & Linda Henry. (2016) Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C. Value in Health 19:5, pages 544-551.
Crossref
Jayne Smith-Palmer, Karin Cerri & William Valentine. (2015) Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits. BMC Infectious Diseases 15:1.
Crossref
David Whiteley, Lawrie Elliott, Sarah Cunningham-Burley & Anne Whittaker. (2015) Health-Related Quality of Life for individuals with hepatitis C: A narrative review. International Journal of Drug Policy 26:10, pages 936-949.
Crossref
Ciro Conversano, Claudia Carmassi, Marina Carlini, Giulia Casu, Paola Gremigni & Liliana Dell’Osso. (2015) Interferon α Therapy in Patients with Chronic Hepatitis C Infection: Quality of Life and Depression. Hematology Reports 7:1, pages 5632.
Crossref
Shu-Chuan Chang, Sheng-Shun Yang, Chiu-Chun Chang, Chun-Che Lin, Yueh-Chin Chung & Tsai-Chung Li. (2014) Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ. Health and Quality of Life Outcomes 12:1.
Crossref
Roger T. Anderson, Robert W. Baran, Birgitta Dietz, Eric Kallwitz, Pennifer Erickson & Dennis A. Revicki. (2013) Development and initial psychometric evaluation of the hepatitis C virus-patient-reported outcomes (HCV-PRO) instrument. Quality of Life Research 23:2, pages 561-570.
Crossref
David Isaacs, Nader Abdelaziz, Majella Keller, Jeremy Tibble & Inam Haq. (2013) Measuring the Response of Extrahepatic Symptoms and Quality of Life to Antiviral Treatment in Patients with Hepatitis C. Hepatitis Research and Treatment 2013, pages 1-7.
Crossref
Renato Daltro-Oliveira, Mychelle Morais-de-Jesus, Karine Miranda Pettersen, Raymundo Paraná & Lucas C. Quarantini. (2013) Impact of sustained virologic response on quality of life in chronic HVC carriers. Annals of Hepatology 12:3, pages 399-407.
Crossref
Nahid Dehghan NayeriAhmad Ali Asadi NoghabiSomayeh Molaee. (2012) The Effect of Telephone Consultation on the Quality of Life of Patients Receiving Interferon Therapy: A Quasi-experimental Study. Telemedicine and e-Health 18:6, pages 459-463.
Crossref
K. K. SNOW, H. L. BONKOVSKY, R. J. FONTANA, H.‐Y. KIM, R. K. STERLING, A. M. DI BISCEGLIE, T. R. MORGAN, J. L. DIENSTAG & M. G. GHANY. (2010) Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics 31:7, pages 719-734.
Crossref
U. Siebert, A. Conrads-Frank, R. Schwarzer, B. Lettmeier, G. Sroczynski, S. Zeuzem & N. Mühlberger. 2010. Handbook of Disease Burdens and Quality of Life Measures. Handbook of Disease Burdens and Quality of Life Measures 1323 1334 .
Nikolai Mühlberger, Ruth Schwarzer, Beate Lettmeier, Gaby Sroczynski, Stefan Zeuzem & Uwe Siebert. (2009) HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 9:1.
Crossref
F. SCHMIDT, G. JANSSEN, G. MARTIN, R. LORENZ, K. LOESCHKE, M. SOYKA, C. FOLWACZNY & M. SCHAEFER. (2009) Factors influencing long‐term changes in mental health after interferon‐alpha treatment of chronic hepatitis C. Alimentary Pharmacology & Therapeutics 30:10, pages 1049-1059.
Crossref
G. R. Foster. (2009) Quality of life considerations for patients with chronic hepatitis C. Journal of Viral Hepatitis 16:9, pages 605-611.
Crossref
Bruce R. SchackmanPaul A. Teixeira, Gil Weitzman, Alvin I. Mushlin & Ira M. Jacobson. (2008) Quality-of-Life Tradeoffs for Hepatitis C Treatment: Do Patients and Providers Agree?. Medical Decision Making 28:2, pages 233-242.
Crossref
Erik J. Groessl, Kimberly R. Weingart, Robert M. Kaplan & Samuel B. Ho. (2009) Health-related quality of life in HCV-infected patients. Current Hepatitis Reports 6:4, pages 169-175.
Crossref
Robert J. Fontana, Linas A. Bieliauskas, Karen L. Lindsay, Carla Back-Madruga, Elizabeth C. Wright, Kristin K. Snow, Anna S.F. Lok, Ziad Kronfol & Latha Padmanabhan. (2007) Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology 45:5, pages 1154-1163.
Crossref
Winfried Häuser. 2007. Psychosomatik in der Gastroenterologie und Hepatologie. Psychosomatik in der Gastroenterologie und Hepatologie 183 206 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.